Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | Series E | $35M | 8 |
Lightrock
|
— | Detail |
| Mar 22, 2022 | Grant | $25.50M | 1 |
Biomedical Advanced Research and Development Authority (BARDA)
|
— | Detail |
| Mar 1, 2022 | Series E | $100M | 9 |
Ping An Global Voyager
|
— | Detail |
| Feb 2, 2021 | Grant | $12.30M | 1 |
Biomedical Advanced Research and Development Authority (BARDA)
|
— | Detail |
| May 4, 2020 | Series D | $70M | 5 |
Cedars Sinai
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lightrock
|
Yes | Series E |
Biomedical Advanced Research and Development Authority (BARDA)
|
Yes | Grant |
Ping An Global Voyager
|
Yes | Series E |
Hutchison Port Group
|
Yes | Series C |
Plug and Play
|
Yes | Series C |
|
|
— | Series E |
Blue Water Life Science Advisors
|
— | Series E |
Cedars Sinai
|
— | Series E |
|
|
— | Series E |
John Doerr
|
— | Series E |